13 The Role of Echocardiographic Evaluation in Patients Presenting with Acute Chest Pain to the Emergency Department
Background and Principles
Coronary artery disease (CAD) accounted for 4.0 million hospital discharges in 2007 with more than 8 million patients presenting each year to emergency departments in the United States with a chief complaint of chest pain.1 The challenge for the clinician is to identify those patients with a serious cause of chest pain requiring intervention. Acute coronary syndrome (ACS) often presents with atypical symptoms and a lack of diagnostic changes in the electrocardiogram (ECG) or cardiac markers. Time is critical when it comes to a patient with chest pain. Early treatment of myocardial injury, as well as other serious diagnoses, improves morbidity and mortality rates. Patients without a clear diagnosis are often admitted for observation as well as further cardiac testing, resulting in significant expense. Of patients presenting with chest pain, fewer than 30% are eventually diagnosed with ACS.2,3 Efficient diagnosis not only aids the patient, but reduces hospitalization time and costs.
The diagnosis of myocardial infarction is based on evidence of myocardial necrosis in a clinical setting consistent with myocardial ischemia.4 Most commonly this involves a change in cardiac biomarkers in conjunction with symptoms, ECG changes, or abnormal cardiac imaging. Use of serum cardiac markers (troponin, CK-MB) is central to the evaluation of chest pain and/or dyspnea in the emergency department. Unfortunately, these markers often take hours from symptom onset to exceed the normal range and are not elevated in acute coronary syndromes that are not associated with frank myocardial necrosis. Depending on the particular cardiac marker, levels can also be elevated in the absence of acute coronary syndrome, such as in the setting of renal insufficiency.5 Electrocardiographic changes are frequently nonspecific.
Given these limitations, echocardiography can be a useful adjunct in assessing the emergency-department patient with chest pain. The evaluation of left ventricular (LV) systolic function, specifically wall thickening, with myocardial perfusion can aid in the diagnosis and triage of patients with chest pain. Echocardiography may also be useful in the diagnosis of other etiologies of chest pain, including aortic dissection, aortic stenosis, hypertrophic cardiomyopathy, and pericardial effusion (Box 13-1). This chapter focuses on the current application of echocardiography for early diagnosis of ACS.
Echocardiography and the Physiology of Acute Ischemia
Acute ischemia is associated with a number of biochemical and physiologic changes in myocardial tissue.6 The ischemic cascade begins with biochemical changes causing subsequent abnormalities in diastolic and systolic function. These abnormalities typically precede the development of symptoms, electrocardiographic changes, or the increase in cardiac biomarker levels.7 The ability to detect myocardial ischemia earlier in the cascade of events by assessment of global and regional function has led to an interest in the use of echocardiography in patients presenting with chest pain without a clear diagnosis of ACS.
In addition, while coronary blood flow is maintained at a constant rate over a wide range of coronary pressure through autoregulation, myocardial contrast echocardiography (MCE) may also be helpful in assessing suspected CAD. Only once a coronary vessel is more than 85% obstructed does the flow fall below a normal threshold.8 However, MCE evaluates myocardial perfusion and thereby may detect severely stenotic lesions noninvasively as well.
Technical Aspects of Echocardiography in the Emergency Department
Image Acquisition
The standard two-dimensional (2D)-TTE views necessary for assessment of wall thickening are the parasternal long- and short-axis views and the apical four-chamber, two-chamber and three-chamber views (Fig. 13-1 demonstrates the apical two-chamber and short-axis views). If adequate image quality cannot be achieved from the parasternal or apical views, subcostal views can be extremely helpful. Off-axis or foreshortened views make the interpretation of regional wall motion abnormalities difficult and increase the likelihood of error. Images should be analyzed in accordance with the American Society of Echocardiography guidelines.9
The use of echocardiographic contrast agents can be invaluable in defining endocardial borders for wall motion analysis (see Chapter 3). Commercially available intravascular echocardiographic contrast agents contain gas-filled microbubbles, which are small enough to pass through the pulmonary circulation, resulting in opacification of the LV. This results in enhancement of endocardial borders (Fig. 13-2).
The advancement of echocardiographic technology has substantially reduced the number of patients with inadequate echocardiographic images. In an early study by Horowitz and colleagues on the use of echocardiography in patients with acute chest pain, adequate images were obtained in 81% of patients.10 A recent study evaluated patients with technically difficult imaging and found that the addition of contrast agent improved the percentage of myocardial segments visualized from 68% to 99%. This improvement had a direct impact on patient care.11
Stress Echocardiography
Treadmill studies image patients at baseline and just after peak exercise only. For maximum sensitivity, it is essential that the echocardiographic imaging begin immediately after exercise terminates, before significant heart rate decrease. This stress modality is primarily for assessment of global and regional systolic function (see Chapter 15).
For patients unable to exercise adequately, pharmacologic stress testing can be performed (see Chapter 16). Dobutamine is the agent most studied and, therefore, most commonly used in North America. Dobutamine stress echocardiography (DSE) has demonstrated excellent negative predictive value for the presence of obstructive CAD (96% at 6 months).12 Baseline images are obtained, followed by the infusion of dobutamine at incremental levels (usually 5, 10, 20, 30, 40 mcg/kg/min) of 3 minutes’ duration. The test is terminated when the patient’s heart rate reaches 85% of maximum predicted heart rate, or there is evidence of myocardial ischemia, hypotension, significant arrhythmia, significant LV outflow tract obstruction, or drug-related side effects. Patients who do not reach target heart rate despite 40 mcg/kg/min of dobutamine can perform handgrip maneuvers or be given intravenous atropine in doses of 0.1 to 0.25 mg up to a total of 1 mg.
Endocardial definition is essential for reliable wall motion assessment. Images during stress decrease in quality because of the cardiac movement and hyperventilation. The use of second harmonic imaging has increased the sensitivity for the diagnosis of CAD from 64% to 92% in patients with poor image quality. Specificity is unchanged with second harmonic imaging.13 The use of echocardiographic contrast agents has also increased the sensitivity of stress echocardiography for the diagnosis of CAD. Rainbird and colleagues14 analyzed 300 consecutive patients undergoing DSE. The percentage of wall segments visualized increased from 94.4% to 99.8% with the use of LV opacification during peak exercise (P less than 0.01). There was no decrease in segment visualization at peak exercise, as was the case if an echocardiographic contrast agent was not used.
This technique has been safely used when performed by specially trained nurses and sonographers, with images electronically transferred to the cardiologist for interpretation.15,16
Image Interpretation
The American Society of Echocardiography recommends a 16-segment model of regional wall motion evaluation (Fig. 13-3).9 This model is consistent with the models used in nuclear and magnetic resonance imaging. Each segment is assigned a score based on visual assessment of contractility: normal = 1, hypokinesis = 2, akinesis = 3, dyskinesis = 4, and aneurysmal = 5. The wall motion score index, a semiquantitative measure of regional wall motion abnormality, is calculated by averaging wall motion scores for visualized segments. An LV with normal systolic function has a wall motion score index of 1, whereas a dysfunctional ventricle will have an increasing wall motion score index proportional to the severity. This score correlates with myocardial infarct size on pathologic studies17 and to perfusion defect size on single photon emission computed tomographic (SPECT) imaging.18 A similar 14-segment wall motion index predicts long-term survival in patients with chest pain.19
Recent refinements in tissue Doppler/speckle tracking imaging and the measurement of myocardial velocity allow for quantitative analysis of regional function.20,21 Although not routine at present, these quantitative measures have been shown to distinguish between patients with non–ST-elevation myocardial infarction and unstable angina or noncoronary chest pain.22
Myocardial Contrast Echocardiography
MCE allows for the assessment of myocardial perfusion with the use of intravenous echocardiographic contrast agents, as well as assessment of wall thickening. Myocardial perfusion is assessed by the injection of microbubbles at the bedside, in real time, with rapid image acquisition. These inert, intravascular microbubbles are delivered to the capillary bed in territories with normal perfusion. Areas that are hypoperfused lack the echocardiographic enhancement generated by the contrast agent (perfusion defect). The difference in areas with and without adequate perfusion is highlighted by destruction of the bubbles at timely intervals, allowing for image acquisition as the areas of normal perfusion increase in signal intensity faster compared to areas with hypoperfusion. The destruction of bubbles occurs with the use of high-intensity pulses (mechanical index 1.0) synchronized to end-systole, whereas imaging occurs at a mechanical index of approximately 0.5 (Fig. 13-4).
Clinical Applications
Triage Of Patients With Chest Pain
Ischemia-induced regional wall motion abnormalities develop quickly once myocardial blood flow falls below a critical level. Rest echocardiography has therefore been used in the assessment of patients with symptoms suggestive of ACS. The diagnostic accuracy has, however, varied vastly between studies, likely because of the following factors: timing in relation to symptoms, infarct size, and technical variation. A recent study of emergency department patients with symptoms suggestive of ACS reported TTE to have a negative predictive value of 97%; however, the positive predictive valve was only 24%.23 Although normal systolic function at rest is reassuring, it is insufficient to exclude the diagnosis of ACS (Table 13-1). The evaluation of wall thickening by TTE is deemed appropriate in patients with suspected ACS but nondiagnostic initial testing.24
Suspected Cause of Chest Pain | Alternate Imaging Techniques |
---|---|
Dissection | Transesophageal echocardiography, CT angiography, MR angiography, aortogram |
Coronary artery disease | CT angiography, nuclear perfusion imaging, left heart catheterization |
Pericarditis/myocarditis | Cardiac MRI |
Pulmonary embolus | Ventilation/perfusion scan, CT angiography, pulmonary angiography |
CT, Computed tomography; MR, magnetic resonance; MRI, magnetic resonance imaging.